Nasdaq17d
Quantum BioPharma Ltd. Announces Positive Results from Clinical Trial of unbuzzd™ Dietary Supplement for Alcohol Intoxication Relief
placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzd™, investigating its effects on alcohol intoxication and alcohol metabolism. Results of ...
Nasdaq17d
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzd™, investigating its effects on alcohol intoxication and alcohol metabolism. Results of ...
Quantum BioPharma stock soars on clinical trial success
BioPharma Ltd. (NASDAQ: QNTM) surged 95% following the announcement of positive results from its clinical trial for the dietary supplement unbuzzd™. The trial confirmed that unbuzzd™ significantly ...
Yahoo Finance18d
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzd™, investigating its effects on alcohol intoxication and alcohol metabolism. Results of data ...